NYSE: LLY
ELI LILLY & Co Earnings & Revenue

LLY past earnings growth

How has LLY's earnings growth performed historically?
Company
-22.63%
Industry
10.68%
Market
82.89%
LLY's earnings have grown faster (26.12% per year) than the US Drug Manufacturers - General industry average (8.89%)
Performance
LLY's earnings have grown slower (26.12% per year) than the US market average (77.34%)
Performance
LLY's earnings growth is slowing down - its growth over the last year (-22.63%) is below its 5-year compound annual rate (26.12%)
Performance

LLY past revenue growth

How has LLY's revenue growth performed historically?
Company
5.89%
Industry
6.62%
Market
16.55%
LLY's revenue has grown slower (3.18% per year) than the US Drug Manufacturers - General industry average (4.07%)
Performance
LLY's revenue has grown slower (3.18% per year) than the US market average (15.67%)
Performance
LLY's revenue growth is accelerating - its growth over the last year (5.89%) is above its 5-year compound annual rate (3.18%)
Performance

LLY earnings and revenue history

Current Revenue
$22.9B
Current Earnings
$5.6B
Current Profit Margin
24.5%
LLY's has not demonstrated consistent long-term earnings growth over the past 10 years (53.22%)
Performance

LLY Return on equity

Current Company
170.7%
Current Industry
10.9%
Current Market
-36.3%
LLY's Return on Equity (170.7%) shows a company that is highly efficient at transforming shareholder equity into returns
Performance

LLY Return on assets

Current Company
14%
Current Industry
8.5%
Current Market
6.2%
LLY is generating higher Return on Assets (14%) than the US Drug Manufacturers - General industry average (8.27%)
Performance

LLY Return on capital employed

Current Company
21.32%
Current Industry
12.8%
LLY has gotten more efficient at generating Return on Capital (21.32%) compared to 3 years ago (10.74%)
Performance

LLY earnings dates

Next earnings date
Oct 27, 2020

ELI LILLY & Earnings & Revenue FAQ

On Apr 23, 2020, ELI LILLY & (NYSE: LLY) reported Q1 2020 earnings per share (EPS) of $1.60, up 63.05% year over year. Total ELI LILLY & earnings for the quarter were $1.46 billion. In the same quarter last year, ELI LILLY &'s earnings per share (EPS) was $4.33.
On Apr 23, 2020, ELI LILLY & (NYSE: LLY) reported Q1 2020 revenue of $5.86 billion up 15.07% year over year. In the same quarter last year, ELI LILLY &'s revenue was $5.09 billion.
As of Q4 2020, ELI LILLY &'s earnings has grown -22.63% year over year. This is 33.31 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 10.68%. ELI LILLY &'s earnings in the past year totalled $5.62 billion.
As of Q4 2020, ELI LILLY &'s revenue has grown 5.89% year over year. This is 0.73 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 6.62%. ELI LILLY &'s revenue in the past year totalled $22.95 billion.
ELI LILLY &'s earnings date is Oct 27, 2020. Add LLY to your watchlist to be reminded of LLY's next earnings announcement.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics